Key Takeaways
- • Carlyle and PAI Partners agreed to sell specialty pharmaceutical company Theramex, according to Private Equity International's 3 November 2026 newsletter.
- • Kristin Kelly, a partner at Houston-based energy-focused private equity firm EIV Capital, is profiled in PEI's Dealmakers to Watch series on the resilience of the oil and gas sector.
- • O2 Investment Partners sold Xobee Networks to Brite, per the same report.
- • Submissions for the PEI Private Equity Awards 2026 are now open.
Summary
Private Equity International's 3 November 2026 newsletter highlighted several developments across the private markets. The lead item is the latest profile in its Dealmakers to Watch series, featuring Kristin Kelly, a partner at Houston-based energy-focused private equity firm EIV Capital. The profile addresses the resilience of the oil and gas sector, though the publisher summary available for this item does not detail her specific views or figures.
In a separate deal, Carlyle and PAI Partners agreed to sell specialty pharmaceutical company Theramex. The source material available for this report does not disclose the transaction value, the identity of the buyer, or the expected timing of closing.
The newsletter also reported that O2 Investment Partners sold Xobee Networks to Brite. Further terms of that transaction were not included in the available source material.
Finally, PEI announced that submissions for its Private Equity Awards 2026 are open, an item of relevance to firms seeking industry recognition.
In a separate deal, Carlyle and PAI Partners agreed to sell specialty pharmaceutical company Theramex. The source material available for this report does not disclose the transaction value, the identity of the buyer, or the expected timing of closing.
The newsletter also reported that O2 Investment Partners sold Xobee Networks to Brite. Further terms of that transaction were not included in the available source material.
Finally, PEI announced that submissions for its Private Equity Awards 2026 are open, an item of relevance to firms seeking industry recognition.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.